The US Food and Drug Administration (FDA) has approved a new formulation of the triazole antifungal posaconazole (Noxafil, Merck), the manufacturer announced today. The agency approved posaconazole ...

The goal of therapy is to reduce urinary cystine concentration below its solubility limit. Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced the launch of mesalamine 800 mg ...

Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets, which can be taken with or without food. Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia ...

FDA approved Amneal's generic lenalidomide capsules, referencing Celgene's Revlimid, for manufacturing and sale starting in 2026. Amneal launched mesalamine 800 mg delayed-release tablets for ...

Mumbai, Nov. 13 -- The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Dexilant Delayed-Release Capsules, 30 mg and 60 mg, of Takeda Pharmaceuticals USA, Inc. (Takeda).

Three years ago, Justin Zheng, an entrepreneur in San Francisco, lay groggy in bed while a group of venture capitalists twiddled their thumbs waiting for him. “I completely forgot this meeting was ...

Matt Fuchs lives in Maryland and writes about health, science, and technology. Matt Fuchs lives in Maryland and writes about health, science, and technology. Three years ago, Justin Zheng, an ...